These results suggest that AV treatment-induced gut microbiota dysbiosis reduces the numbers of DCs and CD8+ T cells in both peripheral blood (Figures 6A, B) and tumor tissues (Figures 6C, D), potentially impairing the immune response and the efficacy of 5-FU chemotherapy for treating CRC. This evidence concerns the gene CD8A and neoplasm.